EDWARD J. RAPP - 30 Jun 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
Steven L. Scrogham, attorney-in-fact for Edward J. Rapp
Issuer symbol
ABBV
Transactions as of
30 Jun 2023
Net transactions value
+$38,668
Form type
4
Filing time
05 Jul 2023, 17:00:15 UTC
Previous filing
14 Jun 2023
Next filing
13 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Stock Equivalent Units Award $38,668 +287 +1.2% $134.73 24,254 30 Jun 2023 Common Stock 287 $134.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.